What should I know first?

Amphetamines affect dopamine and norepinephrine signaling through both reuptake and release. This view uses Adderall XR, an extended-release mixed amphetamine-salt product.

The U.S. Adderall XR label covers ADHD in adults and children aged 6 and older. It has serious misuse and addiction risks. This is not a dose-conversion or product-substitution guide.

This is a mechanism lesson, not a complete medicine guide. A diagram cannot choose treatment, predict your response, or tell you how to change a prescription.

Adderall XR is not recommended for children under 6 because they can have higher drug exposure and more adverse effects, including weight loss. This restriction concerns the named extended-release product; it does not establish the approval or safety of another formulation. For age-specific treatment and monitoring information, see the ADHD medication article.

How Brain Cells Communicate

A nerve ending stores messengers in small packets called vesicles. Releasing a messenger into the space outside a cell and returning it through a transporter are different processes.

Dopamine · DAT

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Dopamine: The messenger is shown outside the sending cell. DAT: The DAT transporter returns dopamine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Dopamine

    The messenger is shown outside the sending cell.

  2. DAT

    The DAT transporter returns dopamine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

The release arrow shows movement to the outside, not a complete transporter cycle or an atomic mechanism. Rates and relative effects are not inferred.
About this illustration

Messenger return runs from outside toward the nerve cell. This is distinct from release from inside to outside.

How the Medication Changes Signaling

Amphetamine pharmacology includes inhibition of dopamine and norepinephrine reuptake and increased release of these messengers outside nerve cells. The outward arrow in the release panel represents the latter effect; it is not the same inward reuptake arrow.

Experiments comparing amphetamine isomers with methylphenidate found different effects on storage and release. The exact effects vary with the preparation and measurement. No universal release rate is shown.

Explore the mechanism

Which direction does release take?

Dopamine · DAT

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Dopamine: The messenger is shown outside the sending cell. DAT: The DAT transporter returns dopamine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Dopamine

    The messenger is shown outside the sending cell.

  2. DAT

    The DAT transporter returns dopamine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Static introduction. The release arrow shows movement to the outside, not a complete transporter cycle or an atomic mechanism. Rates and relative effects are not inferred.

Dopamine · DAT

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Dopamine: The messenger is shown outside the sending cell. DAT: The DAT transporter returns dopamine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Dopamine

    The messenger is shown outside the sending cell.

  2. DAT

    The DAT transporter returns dopamine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Before medicine: reuptakeMessenger return runs from outside toward the nerve cell. This is distinct from release from inside to outside.

Dopamine · DAT

A membrane transporter with uptake reduced; messenger remains outside below the membrane. The separate terracotta symbol denotes a medicine, not its molecular shape. Dopamine: The messenger is shown outside the sending cell. DAT: The DAT transporter returns dopamine into the cell. Amphetamine: uptake inhibited: The interrupted arrow names the action; the symbol is not a molecular shape or binding position.
  1. Dopamine

    The messenger is shown outside the sending cell.

  2. DAT

    The DAT transporter returns dopamine into the cell.

  3. Amphetamine: uptake inhibited

    The interrupted arrow names the action; the symbol is not a molecular shape or binding position.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

A membrane transporter with uptake reduced; messenger remains outside below the membrane. The separate terracotta symbol denotes a medicine, not its molecular shape. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Amphetamine: uptake inhibited: The interrupted arrow names the action; the symbol is not a molecular shape or binding position.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Amphetamine: uptake inhibited

    The interrupted arrow names the action; the symbol is not a molecular shape or binding position.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Reuptake inhibitionAmphetamines inhibit dopamine and norepinephrine reuptake. This panel does not yet represent their additional release effect.

Dopamine · DAT

Sending-cell interior above, a transporter in its membrane and released messenger below. This is a simplified net release example, not the complete molecular route. Dopamine: The messenger is shown outside the sending cell. DAT: The DAT transporter returns dopamine into the cell. Increased release: The outward arrow shows a net effect, not an exclusive molecular route.
  1. Dopamine

    The messenger is shown outside the sending cell.

  2. DAT

    The DAT transporter returns dopamine into the cell.

  3. Increased release

    The outward arrow shows a net effect, not an exclusive molecular route.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

Sending-cell interior above, a transporter in its membrane and released messenger below. This is a simplified net release example, not the complete molecular route. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Increased release: The outward arrow shows a net effect, not an exclusive molecular route.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Increased release

    The outward arrow shows a net effect, not an exclusive molecular route.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Increased releaseThe outward arrow marks increased messenger release into the space outside the nerve cell. This is a qualitative net effect, not a verified animation of every molecular step.

What this model cannot tell us

Clinical mechanism unknown

  • Clinical mechanism unknown The clinical explanation remains uncertain.
  • Limits of inference An experimental result does not by itself predict one person’s treatment response.
Separate clinical questionThe target actions do not fully explain therapeutic effects in ADHD or determine the right medicine for an individual.

Static overview. Start the steps when you are ready.

Guide to the illustration: Outlines identify a cell membrane or target; arrows mark the direction explained in each caption. Medicine symbols are labels, not measured shapes or binding poses. No quantity, size or rate is to scale.

Read the complete sequence
  1. Before medicine: reuptake. Messenger return runs from outside toward the nerve cell. This is distinct from release from inside to outside.
  2. Reuptake inhibition. Amphetamines inhibit dopamine and norepinephrine reuptake. This panel does not yet represent their additional release effect.
  3. Increased release. The outward arrow marks increased messenger release into the space outside the nerve cell. This is a qualitative net effect, not a verified animation of every molecular step.
  4. Separate clinical question. The target actions do not fully explain therapeutic effects in ADHD or determine the right medicine for an individual.
Evidence and model limits

Adderall XR label12.1/12.2; experimental uptake and release in rat nerve-ending/vesicle preparations.

The release arrow shows movement to the outside, not a complete transporter cycle or an atomic mechanism. Rates and relative effects are not inferred.

A Closer Look at the Molecular Level

Known actions: increased release and reuptake inhibition are described in the current Adderall XR label. This formulation contains mixed amphetamine salts, not one newly invented molecule.

Clinical uncertainty: its therapeutic mode of action in ADHD remains unknown. A simplified cell drawing cannot rank stimulant medicines, predict an individual’s response or equate extended-release products.

Sources and References

The sources below support the specific medicine and experimental context described here. Drawings are original qualitative teaching models; positions, arrows and timing do not give atomic geometry, occupancy or rates.

  1. DailyMed: Adderall XR, updated April2026
  2. Easton and colleagues: comparison of stimulant effects in rat preparations
  3. NIH: What Is a Neurotransmitter?

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top